As a hematologist with a keen interest in the intricacies of blood coagulation and its disorders, I often encounter patients and their families seeking information about various conditions that affect the body's ability to form blood clots. One such condition is hemophilia, a genetic disorder characterized by an impaired ability to produce blood clots, which are essential for stopping bleeding after an injury.

Hemophilia is a condition that predominantly affects males and is inherited, usually passed down from mothers to their sons. There are two main types of hemophilia: Hemophilia A and Hemophilia B. Hemophilia A is more common and is caused by a deficiency in clotting factor VIII, while Hemophilia B is less common and is due to a deficiency in clotting factor IX.

Individuals with hemophilia often experience bleeding episodes that can be spontaneous or triggered by an injury. The bleeding can occur in various parts of the body, including joints, muscles, and soft tissues. In severe cases, internal bleeding, particularly into the joints, can lead to chronic pain and joint damage.

The term "free bleeder" is colloquially used to describe someone with hemophilia, particularly in the context of the severity of their bleeding episodes. A free bleeder is someone who bleeds excessively and spontaneously, without a clear cause or with minor provocations. This term is not a medical term and is not used in formal medical discussions. Instead, medical professionals refer to the specific type and severity of hemophilia to describe a patient's condition.

The diagnosis of hemophilia involves a series of tests that assess the blood's clotting ability and the levels of clotting factors. These tests include:


1. Complete Blood Count (CBC): To check for any abnormalities in the number of blood cells.

2. Bleeding Time: To measure how long it takes for a small incision to stop bleeding.
3. **Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT)**: To evaluate the extrinsic and intrinsic clotting pathways, respectively.

4. Factor Assays: To measure the levels of specific clotting factors, such as factor VIII or IX, to determine the type of hemophilia.

5. Molecular Genetic Testing: To identify the specific genetic mutations causing the deficiency in clotting factors.

Treatment for hemophilia primarily involves the replacement of the missing clotting factors through clotting factor concentrates. These are infused into the bloodstream to raise the levels of the deficient clotting factors and help the blood to clot normally. In addition to factor replacement therapy, patients may also require pain management for joint pain, physical therapy to maintain joint mobility, and antifibrinolytic medications to reduce bleeding during dental procedures or surgery.

It is important to note that while hemophilia is a lifelong condition, with appropriate treatment and care, individuals with the disorder can lead healthy, active lives. Regular medical check-ups, proactive management of bleeding episodes, and adherence to a treatment plan are crucial for maintaining the quality of life for those with hemophilia.

In conclusion, the term "free bleeder" is a non-medical term that may be used informally to describe someone with hemophilia. However, in a clinical setting, it is essential to use the correct medical terminology and conduct a thorough evaluation to diagnose and treat this genetic bleeding disorder effectively.

read more >>

Haemophilia, also spelled hemophilia, is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding. ... Diagnosis is by testing the blood for its ability to clot and its levels of clotting factors.read more >>